Bone mass levels may be another indicator to determine a woman's risk of developing breast cancer, researchers have discovered. ...
Women who took diethylstilbestrol (DES) to prevent miscarriages during pregnancy in the Fifties and Sixties have a "statistically significant" increased risk of developing breast cancer (JAMA, 28 ...
New evidence from the Netherlands shows that long term tamoxifen use increases the risk of endometrial cancers with a poor prognosis. ...
A large scale study of all former trials of breast cancer risks with hormone replacement therapy shows a definite link between a risk of cancer and length of use. At the same time two cautionary ...
The breast cancer drug tamoxifen-marketed in the UK as Emblon, Noltam and Tamofen, and as Nolvadex in the US and the UK-has been enjoying some favourable press comment recently. ...
In contrast with popular opinion that a daily glass of wine is good for you, women who drink are far more at risk from breast cancer than those who do not touch a drop of alcohol. ...
Have you any up-to-date information on anastrozole, which I have been taking for two and a half years, following breast cancer in 1996 and lymph-node secondaries in 2002? I sensed some concern regarding this drug on my last check-up, when the...
The largest trial in the US on breast cancer which began the shift away from mastectomy as the preferred treatment was falsified (BMJ, 26 March 1994). About 100 ineligible patients were included i ...
The Lancet - that bastion of medical orthodoxy is calling for a major rethink in breast cancer treatment and an admission from the medical profession of the failure of existing treatments. ...
There is growing evidence that those proposing to prescribe the drug tamoxifen as a preventative measure to women supposedly at high risk of breast cancer are simply trading one form of the diseas ...